Relmada Therapeutics Cash from Financing (TTM) Trends

Relmada Therapeutics Inc (RLMD)

3.78 +0.08 (+2.16%) USD | NASDAQ | Apr 26, 12:48

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	-0.0985M
September 30, 2023	0.4099M
June 30, 2023	0.979M
March 31, 2023	15.07M
December 31, 2022	45.02M
September 30, 2022	206.45M
June 30, 2022	206.06M
March 31, 2022	215.96M
December 31, 2021	187.94M
September 30, 2021	27.05M
June 30, 2021	28.50M
March 31, 2021	27.40M
December 31, 2020	28.47M
September 30, 2020	28.70M
June 30, 2020	37.89M
March 31, 2020	16.64M
September 30, 2019	18.32M
June 30, 2019	17.48M
March 31, 2019	6.903M
December 31, 2018	5.207M

Date	Value
September 30, 2018	2.907M
June 30, 2018	6.543M
March 31, 2018	6.258M
December 31, 2017	6.232M
September 30, 2017	3.791M
June 30, 2017	-0.2737M
March 31, 2017	-0.2461M
December 31, 2016	-0.2522M
September 30, 2016	-0.2857M
June 30, 2016	-0.2638M
March 31, 2016	-0.2575M
December 31, 2015	-0.1971M
September 30, 2015	8.909M
June 30, 2015	13.16M
March 31, 2015	13.15M
December 31, 2014	13.18M
September 30, 2014	4.179M
February 28, 2014	0.02M
November 30, 2013	0.02M
August 31, 2013	0.02M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.0985M

Minimum

Dec 2023

215.96M

Maximum

Mar 2022

61.57M

Average

27.94M

Median

Cash from Financing (TTM) Benchmarks